RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway

Published:2024-03-05 Issue:1 Volume:25 Page:
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Sun Qian¹,Xu Junjie²,Yuan Fan’en¹³,Liu Yan⁴,Chen Qianxue¹,Guo Lirui¹,Dong Huimin⁵,Liu Baohui¹^ORCID

Affiliation:

1. Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China

2. Office of director, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China

3. Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA

4. Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China

5. Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2024.2321770

Reference46 articles.

1. Glioblastoma under Siege: An Overview of Current Therapeutic Strategies

2. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

3. Management of glioblastoma: State of the art and future directions

4. Temozolomide resistance in glioblastoma multiforme

5. The RND1 Small GTPase: Main Functions and Emerging Role in Oncogenesis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP